Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel V Lévesque

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 9, 2012
Target-induced SOFA-HDV ribozymeMichel V Lévesque, Jean-Pierre Perreault
Nucleic Acid Therapeutics|July 29, 2011
Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targetingMichel V Lévesque, Samuel G Rouleau, Jean-Pierre Perreault
Plos One|March 13, 2010
Investigating a new generation of ribozymes in order to target HCVMichel V Lévesque, Dominique Lévesque, Francis P Brière, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 10, 2013
Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNARobert J Scarborough, Michel V Lévesque, Jean-Pierre Perreault, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNARobert J Scarborough, Michel V Lévesque, Etienne Boudrias-Dalle, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|February 9, 2012
Target-induced SOFA-HDV ribozymeMichel V Lévesque, Jean-Pierre Perreault
Nucleic Acid Therapeutics|July 29, 2011
Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targetingMichel V Lévesque, Samuel G Rouleau, Jean-Pierre Perreault
Plos One|March 13, 2010
Investigating a new generation of ribozymes in order to target HCVMichel V Lévesque, Dominique Lévesque, Francis P Brière, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 10, 2013
Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNARobert J Scarborough, Michel V Lévesque, Jean-Pierre Perreault, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNARobert J Scarborough, Michel V Lévesque, Etienne Boudrias-Dalle, et al.
Pageof 1